Date Filed | Type | Description |
02/01/2019 |
GN
| Consolidated Research: 2019 Summary Expectations for Micron Technology, Quidel, Ligand Pharmaceuticals, Altra Industrial Motion, USG, and Equity Lifestyle Properties — Fundamental Analysis, Key Performance Indications |
12/17/2018 |
GN
| Analysis: Positioning to Benefit within Quidel, Granite Construction, FireEye, Consolidated Edison, EnPro Industries, and Blueprint Medicines — Research Highlights Growth, Revenue, and Consolidated Results |
05/08/2018 |
BW
| Quidel Reports First Quarter 2018 Financial Results |
04/23/2018 |
BW
| Quidel to Hold First Quarter 2018 Financial Results Conference Call on May 8, 2018 |
04/18/2018 |
GN
| New Research Coverage Highlights Quidel, Eros International, Hennessy Capital Acquisition Corp. II, United Dominion Realty Trust, Fidus Investment, and Kadant — Consolidated Revenues, Company Growth, and Expectations for 2018 |
03/27/2018 |
BW
| Quidel to Host 2018 Analyst and Investor Day in Chicago |
02/26/2018 |
BW
| Quidel to Present at Upcoming Conferences |
02/21/2018 |
BW
| Quidel Reports Fourth Quarter and Full Year 2017 Financial Results |
02/07/2018 |
BW
| Quidel to Hold Fourth Quarter and Full Year 2017 Financial Results Conference Call on February 21, 2018 |
12/21/2017 |
BW
| Quidel to Present at 36th Annual J.P. Morgan Healthcare Conference |
12/19/2017 |
BW
| Quidel Files Form 8-K/A, Reports Historical and Pro Forma Financial Information for Acquired Triage Assets and Combined Quidel and Triage Businesses |
12/13/2017 |
BW
| Quidel Announces Timing of Filing of Form 8-K/A To Report Historical and Pro Forma Financial Information for Acquired Triage Assets and Combined Quidel and Triage Businesses |
11/01/2017 |
BW
| Quidel Reports Third Quarter 2017 Financial Results |
10/13/2017 |
BW
| Quidel to Hold Third Quarter 2017 Financial Results Conference Call on November 1, 2017 |
09/18/2017 |
BW
| Quidel Announces Revised Agreement for Its Pending Acquisition of Alere's B-type Naturietic Peptide (BNP) Assay Business Run on Beckman Coulter Analyzers |
07/26/2017 |
BW
| Quidel Reports Second Quarter 2017 Financial Results |
07/17/2017 |
BW
| Quidel Announces Definitive Agreement to Acquire Alere Triage® Assets |
07/14/2017 |
BW
| Quidel to Hold Second Quarter 2017 Financial Results Conference Call on July 26, 2017 |
02/24/2011 |
BW
| Quidel Reports Fourth Quarter and Full Year 2010 Results |
10/27/2010 |
BW
| Quidel Reports Third Quarter 2010 Results |
10/13/2010 |
BW
| Quidel to Hold Third Quarter 2010 Results Conference Call on October 27, 2010 |
09/29/2010 |
BW
| Quidel Announces FDA Clearance of Its QuickVue® RSV 10 Immunoassay Diagnostic Test |
08/31/2010 |
BW
| Quidel Announces FDA Clearance of Its RapidVue® hCG Pregnancy Lateral Flow Diagnostic Test |
07/30/2010 |
BW
| Quidel to Present at Wedbush Life Sciences Best Ideas Management Access Conference |
07/29/2010 |
BW
| Quidel Reports Second Quarter 2010 Results |
07/26/2010 |
BW
| Quidel Announces the Availability of Its QuickVue®+ Infectious Mononucleosis Lateral Flow Diagnostic Test |
07/08/2010 |
BW
| Quidel to Hold Second Quarter 2010 Results Conference Call on July 29, 2010 |
04/29/2010 |
BW
| Quidel Reports First Quarter 2010 Results |
04/15/2010 |
BW
| Quidel to Hold First Quarter 2010 Results Conference Call on April 29, 2010 |